These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19763139)

  • 1. Adenosine signaling and function in glial cells.
    Boison D; Chen JF; Fredholm BB
    Cell Death Differ; 2010 Jul; 17(7):1071-82. PubMed ID: 19763139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and ATP receptors in the brain.
    Burnstock G; Fredholm BB; Verkhratsky A
    Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of glial cell functions by adenosine receptors.
    Daré E; Schulte G; Karovic O; Hammarberg C; Fredholm BB
    Physiol Behav; 2007 Sep; 92(1-2):15-20. PubMed ID: 17574632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosinergic signaling in epilepsy.
    Boison D
    Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of nerve and glial function by adenosine--role in the development of ischemic damage.
    Schubert P; Rudolphi KA; Fredholm BB; Nakamura Y
    Int J Biochem; 1994; 26(10-11):1227-36. PubMed ID: 7531656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glia, adenosine, and sleep.
    Jones BE
    Neuron; 2009 Jan; 61(2):156-7. PubMed ID: 19186158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of adenosine receptors in neuroprotection.
    Ribeiro JA; Sebastiao AM; de Mendonca A
    Drug News Perspect; 2003 Mar; 16(2):80-6. PubMed ID: 12792668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic neurone-glia signalling in cognitive-related pathologies.
    Illes P; Verkhratsky A
    Neuropharmacology; 2016 May; 104():62-75. PubMed ID: 26256423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does adenosine control neuronal dysfunction and neurodegeneration?
    Cunha RA
    J Neurochem; 2016 Dec; 139(6):1019-1055. PubMed ID: 27365148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders.
    Kitamura Y; Nomura Y
    Pharmacol Ther; 2003 Jan; 97(1):35-53. PubMed ID: 12493534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptors in the nervous system: pathophysiological implications.
    Ribeiro JA; Sebastião AM; de Mendonça A
    Prog Neurobiol; 2002 Dec; 68(6):377-92. PubMed ID: 12576292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine and related drugs in brain diseases: present and future in clinical trials.
    Lopes LV; Sebastião AM; Ribeiro JA
    Curr Top Med Chem; 2011; 11(8):1087-101. PubMed ID: 21401493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective mechanisms of adenosine in neurons and glial cells.
    Schubert P; Ogata T; Marchini C; Ferroni S; Rudolphi K
    Ann N Y Acad Sci; 1997 Oct; 825():1-10. PubMed ID: 9369970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of A(1) adenosine receptors in osmotic volume regulation of retinal glial cells in mice.
    Wurm A; Lipp S; Pannicke T; Linnertz R; Färber K; Wiedemann P; Reichenbach A; Bringmann A
    Mol Vis; 2009 Sep; 15():1858-67. PubMed ID: 19756184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches.
    Pagonopoulou O; Efthimiadou A; Asimakopoulos B; Nikolettos NK
    Neurosci Res; 2006 Sep; 56(1):14-20. PubMed ID: 16846657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of adenosine and P2Y receptors expressed by multiple cell types in pain transmission.
    Magni G; Ceruti S
    Brain Res Bull; 2019 Sep; 151():132-143. PubMed ID: 30797817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuro-glial-vascular interrelations in genomic instability symptoms.
    Barzilai A
    Mech Ageing Dev; 2011 Aug; 132(8-9):395-404. PubMed ID: 21689674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signalling in neuron-glia interactions.
    Fields RD; Burnstock G
    Nat Rev Neurosci; 2006 Jun; 7(6):423-36. PubMed ID: 16715052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic signaling orchestrating neuron-glia communication.
    Agostinho P; Madeira D; Dias L; Simões AP; Cunha RA; Canas PM
    Pharmacol Res; 2020 Dec; 162():105253. PubMed ID: 33080321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.